PharmacoEconomics & Outcomes News Weekly


ISSN: 1173-5503        年代:2003
当前卷期:Volume &NA;  issue 401     [ 查看所有卷期 ]

年代:2003
 
     Volume 421  issue &NA;   
     Volume &NA;  issue 394   
     Volume &NA;  issue 395   
     Volume &NA;  issue 396/397   
     Volume &NA;  issue 398   
     Volume &NA;  issue 399   
     Volume &NA;  issue 400   
     Volume &NA;  issue 401
     Volume &NA;  issue 402   
     Volume &NA;  issue 403   
     Volume &NA;  issue 404   
     Volume &NA;  issue 405   
     Volume &NA;  issue 406   
     Volume &NA;  issue 407   
     Volume &NA;  issue 408/09   
     Volume &NA;  issue 410   
     Volume &NA;  issue 411   
     Volume &NA;  issue 412   
     Volume &NA;  issue 413   
     Volume &NA;  issue 414   
     Volume &NA;  issue 415   
     Volume &NA;  issue 416   
     Volume &NA;  issue 417   
     Volume &NA;  issue 418   
     Volume &NA;  issue 419   
     Volume &NA;  issue 420   
     Volume &NA;  issue 422   
     Volume &NA;  issue 423   
     Volume &NA;  issue 424   
     Volume &NA;  issue 425   
     Volume &NA;  issue 426   
     Volume &NA;  issue 427   
     Volume &NA;  issue 428   
     Volume &NA;  issue 429   
     Volume &NA;  issue 430   
     Volume &NA;  issue 431   
     Volume &NA;  issue 432   
     Volume &NA;  issue 433   
     Volume &NA;  issue 434   
     Volume &NA;  issue 435   
     Volume &NA;  issue 436   
     Volume &NA;  issue 437   
     Volume &NA;  issue 438   
     Volume &NA;  issue 439   
     Volume &NA;  issue 440   
     Volume &NA;  issue 441   
     Volume &NA;  issue 442   
     Volume &NA;  issue 443   
1. A new programme assessing the safety and efficacy of new interventional procedures has been launched by the UK National Institute for Clinical Excellence
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  2-2

&NA;,  

Preview

2. Towards an ideal economic clinical trial
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  3-4

&NA;,  

Preview

3. Most hospitals have policies and procedures in place for the use of herbal medicines, but herbal formularies are"rare",
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  5-5

&NA;,  

Preview

4. Donepezil warranted in mild-to-moderate AD
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  6-6

&NA;,  

Preview

5. Education needed to increase 'flu vaccination rates among elderly
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  7-7

&NA;,  

Preview

6. HIV-1 infections intervention in Uganda inadequate
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  8-8

&NA;,  

Preview

7. Herbal medicines frequently used by surgery patients in Canada
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  9-9

&NA;,  

Preview

8. Family physicians most likely to prescribe antidepressants to elderly
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  10-10

&NA;,  

Preview

9. US Medicare drug plan expected to benefit pharma
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  11-11

&NA;,  

Preview

10. US seniors are retaliating against GlaxoSmithKline's (GSK) late January decision to suspend drug sales to wholesalers and pharmacies in Canada,
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  401,   2003,   Page  12-12

&NA;,  

Preview

首页 上一页 下一页 尾页 第1页 共10条